Manish Thapar

1.2k total citations
29 papers, 414 citations indexed

About

Manish Thapar is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Manish Thapar has authored 29 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pediatrics, Perinatology and Child Health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Manish Thapar's work include Porphyrin Metabolism and Disorders (17 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers) and Neonatal Health and Biochemistry (12 papers). Manish Thapar is often cited by papers focused on Porphyrin Metabolism and Disorders (17 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers) and Neonatal Health and Biochemistry (12 papers). Manish Thapar collaborates with scholars based in United States, Spain and Italy. Manish Thapar's co-authors include Herbert L. Bonkovsky, Weihong Hou, Jun‐tao Guo, Tarun Narang, Ting Li, Charles Parker, Brendan M. McGuire, Ashwani K. Singal, Lawrence Liu and Richard W. Lambrecht and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Manish Thapar

27 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manish Thapar United States 11 310 115 96 56 23 29 414
A. Edixhoven‐Bosdijk Netherlands 9 165 0.5× 80 0.7× 128 1.3× 17 0.3× 10 0.4× 18 312
Steven Kane United States 11 90 0.3× 63 0.5× 80 0.8× 42 0.8× 22 1.0× 22 423
Donald J. Ostrow United States 11 203 0.7× 231 2.0× 116 1.2× 10 0.2× 21 0.9× 16 356
Antonín Libra Czechia 13 129 0.4× 179 1.6× 25 0.3× 10 0.2× 44 1.9× 23 542
E. Monn Norway 13 121 0.4× 98 0.9× 72 0.8× 46 0.8× 25 1.1× 42 460
Chi Yang Taiwan 13 162 0.5× 34 0.3× 36 0.4× 144 2.6× 27 1.2× 19 407
Paul A. Schmeltzer United States 9 149 0.5× 32 0.3× 45 0.5× 39 0.7× 144 6.3× 15 379
Git Chung United Kingdom 9 160 0.5× 91 0.8× 34 0.4× 9 0.2× 16 0.7× 14 381
Pedro Viana Pinto Portugal 9 91 0.3× 105 0.9× 46 0.5× 12 0.2× 9 0.4× 22 292
Farhad Zaker Iran 13 126 0.4× 41 0.4× 78 0.8× 45 0.8× 5 0.2× 51 448

Countries citing papers authored by Manish Thapar

Since Specialization
Citations

This map shows the geographic impact of Manish Thapar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish Thapar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish Thapar more than expected).

Fields of papers citing papers by Manish Thapar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manish Thapar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish Thapar. The network helps show where Manish Thapar may publish in the future.

Co-authorship network of co-authors of Manish Thapar

This figure shows the co-authorship network connecting the top 25 collaborators of Manish Thapar. A scholar is included among the top collaborators of Manish Thapar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manish Thapar. Manish Thapar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dickey, Amy K., Herbert L. Bonkovsky, Manisha Balwani, et al.. (2025). Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trial. Journal of the American Academy of Dermatology. 94(4). 1167–1176.
2.
3.
Thapar, Manish, et al.. (2024). Obstacles to Early Diagnosis of Acute Hepatic Porphyria: Current Perspectives on Improving Early Diagnosis and Clinical Management. Clinical and Experimental Gastroenterology. Volume 17. 1–8. 1 indexed citations
4.
Dickey, Amy K., Sioḃán Keel, Herbert L. Bonkovsky, et al.. (2024). Results from the Aurora Study: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin in Erythropoietic Protoporphyria. Blood. 144(Supplement 1). 1089–1089. 1 indexed citations
5.
6.
Kuter, David J., Herbert L. Bonkovsky, Gayle Ross, et al.. (2023). Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial. Journal of Hepatology. 79(5). 1150–1158. 27 indexed citations
7.
Levy, Cynthia, Karl E. Anderson, Manisha Balwani, et al.. (2023). PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA. HemaSphere. 7(S3). e904346e–e904346e. 1 indexed citations
8.
Moghe, Akshata, Amy K. Dickey, Angelika Erwin, et al.. (2023). Acute hepatic porphyrias: Recommendations for diagnosis and management with real-world examples. Molecular Genetics and Metabolism. 140(3). 107670–107670. 4 indexed citations
9.
Cassiman, David, Raili Kauppinen, Ming‐Jen Lee, et al.. (2022). EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms. Journal of Inherited Metabolic Disease. 45(6). 1163–1174. 14 indexed citations
10.
Wang, Bruce, Paolo Ventura, Manish Thapar, et al.. (2022). Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study. Orphanet Journal of Rare Diseases. 17(1). 327–327. 20 indexed citations
11.
Thapar, Manish, Sean Rudnick, & Herbert L. Bonkovsky. (2020). Givosiran, a novel treatment for acute hepatic porphyrias. Expert Review of Precision Medicine and Drug Development. 6(1). 9–18. 12 indexed citations
12.
Thapar, Manish, et al.. (2015). Management of Hepatic Adenomatosis. Current Gastroenterology Reports. 17(3). 12–12. 5 indexed citations
13.
Singal, Ashwani K., et al.. (2014). Liver transplantation in the management of porphyria. Hepatology. 60(3). 1082–1089. 90 indexed citations
14.
Bonkovsky, Herbert L., Jun‐tao Guo, Weihong Hou, et al.. (2013). Porphyrin and Heme Metabolism and the Porphyrias. Comprehensive physiology. 3(1). 365–401. 7 indexed citations
15.
Bonkovsky, Herbert L., Jun‐tao Guo, Weihong Hou, et al.. (2012). Porphyrin and Heme Metabolism and the Porphyrias. Comprehensive physiology. 3(1). 365–401. 130 indexed citations
16.
Thapar, Manish. (2012). DNA methylation patterns in alcoholics and family controls. World Journal of Gastrointestinal Oncology. 4(6). 138–138. 13 indexed citations
17.
Choudhary, Abhishek, Nicholas M. Szary, Murtaza Arif, et al.. (2010). S1443: Does Guidewire Use Prevent Post-ERCP Pancreatitis? A Meta-Analysis of Randomized Controlled Trials. Gastrointestinal Endoscopy. 71(5). AB163–AB163. 1 indexed citations
18.
Choudhary, Abhishek, Nicholas M. Szary, Murtaza Arif, et al.. (2010). T1533: Does Guidewire Use in the Pancreatic Duct During Deep Biliary Cannulation Prevent Post-ERCP Pancreatitis? A Meta-Analysis. Gastrointestinal Endoscopy. 71(5). AB302–AB302. 1 indexed citations
19.
Lambrecht, Richard W., Manish Thapar, & Herbert L. Bonkovsky. (2007). Genetic Aspects of Porphyria Cutanea Tarda. Seminars in Liver Disease. 27(1). 99–108. 25 indexed citations
20.
Bhargava, Manorama, et al.. (1976). Impairment of Platelet Adhesiveness and Platelet Factor 3 Activity in Cyanotic Congenital Heart Disease. Acta Haematologica. 55(4). 216–223. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Edixhoven‐Bosdijk Breakdown of academic impact, for papers by Steven Kane Breakdown of academic impact, for papers by Donald J. Ostrow Breakdown of academic impact, for papers by Antonín Libra Breakdown of academic impact, for papers by E. Monn Breakdown of academic impact, for papers by Chi Yang Breakdown of academic impact, for papers by Paul A. Schmeltzer Breakdown of academic impact, for papers by Git Chung Breakdown of academic impact, for papers by Pedro Viana Pinto Breakdown of academic impact, for papers by Farhad Zaker
Rankless by CCL
2026